Board of Directors
Robert L. Chioini
Founder, Chairman, Chief Executive Officer and President
Robert L. Chioini, 52, is the Founder, Chairman, Chief Executive Officer and President of Rockwell Medical, Inc. Mr. Chioini has served as the Chairman since March 2000, as well as the President and Chief Executive Officer since January 1995. In addition, Mr. Chioini is a Board Member of Medical Mainstreet, an alliance of world-class hospitals, universities, medical device and biopharmaceutical companies creating a global center of innovation in health care, research and development, education and commercialization in the life sciences industry in Oakland County, Michigan. Prior to founding Rockwell, Mr. Chioini served as Regional Sales Manager for Dial Medical of Florida, Inc., from 1993 to 1995, which was then acquired by Gambro HealthCare, Inc. Earlier in his career, Mr. Chioini served in sales, management and marketing capacities with medical manufacturing companies. Mr. Chioini is a graduate of Michigan State University and earned his Bachelor's degree in 1987.
Patrick J. Bagley
Patrick J. Bagley, 52, has been a Director since July 2005. Mr. Bagley is Senior Partner of the law firm Bagley and Langan, P.L.L.C. and has been a practicing attorney since 1995 with a focus on general legal matters and litigation. Since 1987, Mr. Bagley has been a licensed insurance agent certified in property and casualty insurance and certified in life, accident and health insurance. Mr. Bagley has started and managed numerous businesses including three different national franchises of retail service businesses. In addition, since 1988, Mr. Bagley has been a licensed real estate agent, real estate developer and real estate investor. .
Ronald D. Boyd
Ronald D. Boyd, 54, has been a Director since March 2000. Mr. Boyd has over 26 years of experience in the dialysis industry, including the ownership and operation of dialysis clinics as well as experience in dialysis product design, product development, regulatory approval and marketing. He has also been a private investor for many years. He currently is an owner and managing partner of Southeast Acute Services, LLC and Southern Renal Administrations, LLC, which is primarily in the business of acute dialysis services, since 2001. He was a founder and Managing Partner of East Georgia Regional Dialysis Center, an outpatient, freestanding dialysis center located in southern Georgia from 2001 until 2005. The facility was purchased by Davita, Inc. He was a founder of Diatek, Inc. in 2001 where he developed, designed and holds the patent to the Cannon Cath. the first “retrograde” dual lumen dialysis catheter in the market. The company has since been sold to Arrow International. He was a founder and co-owner of Classic Medical, Inc., a dialysis and medical products company, and served as the Executive Vice President of Classic Medical, Inc. since its inception in November 1993 until April 2007 when he sold his interest in that company. Following that sale, Mr. Boyd has been a private investor. From May 1993 to November 1993, Mr. Boyd served as a consultant for Dial Medical of Florida, Inc., a manufacturer and distributor of dialysis products. From 1990 to 1993, Mr. Boyd served as a Regional Sales Manager for Future Tech, Inc., a dialysis products distributor. .
Kenneth L. Holt
Kenneth L. Holt, 64, has been a Director since March 2000. Mr. Holt has over 25 years of experience in the dialysis industry, including the management and operation of dialysis clinics, and has also been a private investor for many years. He is currently an owner and a managing partner of two firms that provide contractual dialysis services; Southeast Acute Services, LLC and Southern Renal Administrators, since 2001. He was a founder and co-owner of Charleston Renal Care, LLC, a kidney disease management company specializing in the treatment of end-stage renal disease (ESRD), until its sale to Davita, Inc. in 2005, and since then has been a private investor. He was a founder and co-owner of Savannah Dialysis Specialists, LLC, a disease management company specializing in the treatment of ESRD, and served as the Managing Partner from October 1999 until its sale to Davita, Inc. in 2004. From 1996 to October 1999, Mr. Holt served as Vice President for Gambro Healthcare, Inc., in its Carolinas Region, and held the same position at Vivra Renal Care, Inc., its predecessor company, which was acquired in 1997 by Gambro Healthcare, Inc. From 1986 to 1996, Mr. Holt was also the co-owner and Managing Partner of five dialysis clinics that he founded, which serviced approximately 350 dialysis patients .
Dr. Robin Smith
Dr. Robin Smith, 51, has extensive strategic, operational and management experience in the biopharmaceutical industry. She is the former CEO of the NeoStem family of companies, which she led as CEO from 2006 to 2015 and established as one of the preeminent healthcare brands focused on the development of cellular therapies. During her tenure, Dr. Smith pioneered the company's innovative business model building proprietary cell therapy development and a successful commercial contract and manufacturing organization. At NeoStem, Dr. Smith raised over $200 million while completing six acquisitions and one divestiture of a company in the pharmaceutical space that achieved a doubling of revenues during her tenure. Dr. Smith has also held various board positions and served in senior management roles for numerous medical and healthcare based entities. In 2008, Dr. Smith founded The Stem For Life Foundation (SFLF), a nonpartisan, 501(c)3 educational organization devoted to fostering global awareness of the potential for regenerative medicine to treat and cure a range of deadly diseases and debilitating medical conditions, as opposed to merely treating their symptoms. Dr. Smith is a 2016 recipient of the Women of Power and Influence Awards and winner of the 2014 Brava Award, which recognizes top women business leaders in the Greater New York area. She also writes a regular column on healthcare topics for The Huffington Post. Dr. Smith earned a MD degree from Yale University and an MBA from the Wharton School of Business.